Exact Mass: 351.1471

Exact Mass Matches: 351.1471

Found 157 metabolites which its exact mass value is equals to given mass value 351.1471, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lomefloxacin

(+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid

C17H19F2N3O3 (351.1394)


Lomefloxacin is only found in individuals that have used or taken this drug. It is a fluoroquinolone antibiotic, used to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.Lomefloxacin is a bactericidal fluoroquinolone agent with activity against a wide range of gram-negative and gram-positive organisms. The bactericidal action of lomefloxacin results from interference with the activity of the bacterial enzymes DNA gyrase and topoisomerase IV, which are needed for the transcription and replication of bacterial DNA. DNA gyrase appears to be the primary quinolone target for gram-negative bacteria. Topoisomerase IV appears to be the preferential target in gram-positive organisms. Interference with these two topoisomerases results in strand breakage of the bacterial chromosome, supercoiling, and resealing. As a result DNA replication and transcription is inhibited. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

trans-zeatin riboside

(2R,3R,4S,5R)-2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


Trans-zeatin riboside, also known as (E)-N-(4-hydroxy-3-methyl-2-butenyl)adenosine or 9-beta-D-ribofuranosyl-trans-zeatin, is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Trans-zeatin riboside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Trans-zeatin riboside can be found in a number of food items such as winter squash, plains prickly pear, dill, and common buckwheat, which makes trans-zeatin riboside a potential biomarker for the consumption of these food products. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins Acquisition and generation of the data is financially supported in part by CREST/JST. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

O-beta-D-Xyloxylzeatin

O-beta-D-Xylosylzeatin; O-beta-D-Xyloxylzeatin

C15H21N5O5 (351.1543)


   

Ochotensine

(+)-Ochotensine

C21H21NO4 (351.1471)


   

Zindoxifene

Zindoxifene

C21H21NO4 (351.1471)


C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

   

cis-zeatin riboside

cis-zeatin riboside

C15H21N5O5 (351.1543)


   

ribosylzeatin

(3R,4S,5R)-2-(((E)-4-((7H-purin-6-yl)amino)-2-methylbut-2-en-1-yl)oxy)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;trans-Zeatinriboside

C15H21N5O5 (351.1543)


9-ribosyl-trans-zeatin is a 9-ribosylzeatin having trans-zeatin as the nucleobase. It has a role as a plant metabolite and a cytokinin. It is a nucleoside analogue and a 9-ribosylzeatin. It is functionally related to an adenosine. Zeatin riboside is a natural product found in Rhodococcus fascians, Pseudomonas syringae, and other organisms with data available. D006133 - Growth Substances > D010937 - Plant Growth Regulators > D003583 - Cytokinins A 9-ribosylzeatin having trans-zeatin as the nucleobase. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

9-(beta-D-Ribofuranosyl)zeatin

2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


9-(beta-D-Ribofuranosyl)-(Z)-Zeatin is found in alfalfa. Zeatin is a plant hormone derived from the purine adenine. It is a member of the plant growth hormone family known as cytokinins. Zeatin was first discovered in immature corn kernels from the genus Zea. Zeatin and derivatives were discovered to be the primary active ingredient in coconut milk, which has long been known to actively induce plant growth. As in the case of kinetin, zeatin has also been reported to have several in vitro anti-aging effects on human skin fibroblasts.(Wikipedia). Isolated from many plants. (E)-Ribosylzeatin is found in many foods, some of which are cauliflower, chicory, chayote, and wild carrot. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

benfluorex

2-({1-[3-(trifluoromethyl)phenyl]propan-2-yl}amino)ethyl benzoic acid

C19H20F3NO2 (351.1446)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D009676 - Noxae > D000963 - Antimetabolites

   

Estradiol sulfamate

(17-Hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl) sulfamate

C18H25NO4S (351.1504)


   

cis-zeatin riboside

2-(6-{[(2Z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


Cis-zeatin riboside is a member of the class of compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Cis-zeatin riboside is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Cis-zeatin riboside can be found in a number of food items such as american pokeweed, sesbania flower, moth bean, and common chokecherry, which makes cis-zeatin riboside a potential biomarker for the consumption of these food products.

   

9-Ribosyl-cis-zeatin

6-(4-Hydroxy-3-methyl-cis-2-butenylamino)-9-beta-D-ribofuranosylpurine

C15H21N5O5 (351.1543)


   

Dehydroglaucine

Dehydroglaucine

C21H21NO4 (351.1471)


   

O-Demethyl-buchenavianine

O-Demethyl-buchenavianine

C21H21NO4 (351.1471)


   

benfluorex

benfluorex

C19H20F3NO2 (351.1446)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D019440 - Anti-Obesity Agents > D001067 - Appetite Depressants C78272 - Agent Affecting Nervous System > C29728 - Anorexiant D009676 - Noxae > D000963 - Antimetabolites

   

Maybridge2_000779

Maybridge2_000779

C22H19F2NO (351.1435)


   

N-(2-Hydroxycyclopentyl)adenosine

N-(2-Hydroxycyclopentyl)adenosine

C15H21N5O5 (351.1543)


   

(-)-phyllosteminine|Phyllosteminine

(-)-phyllosteminine|Phyllosteminine

C21H21NO4 (351.1471)


   

9-(beta-D-Ribofuranosyl)zeatin

9-(beta-D-Ribofuranosyl)zeatin

C15H21N5O5 (351.1543)


   
   

methyldambullin|N-Me-Dambullin

methyldambullin|N-Me-Dambullin

C18H25NO4S (351.1504)


   

Validoxylamine G

Validoxylamine G

C14H25NO9 (351.1529)


   

SCHEMBL5160426

SCHEMBL5160426

C14H25NO9 (351.1529)


   

(+)-(6aR,7R)-N-butyrylnorushinsunine

(+)-(6aR,7R)-N-butyrylnorushinsunine

C21H21NO4 (351.1471)


   

castanospermine-8-O-beta-D-glucopyranoside

castanospermine-8-O-beta-D-glucopyranoside

C14H25NO9 (351.1529)


   

CHEMBL2029616

CHEMBL2029616

C21H21NO4 (351.1471)


   

O-Demethylbuchenavianine

O-Demethylbuchenavianine

C21H21NO4 (351.1471)


A piperidine alkaloid that consists of 5,7-dihydroxyflavone attached to a 1-methylpiperindin-2-yl moiety at position 8. It is a flavonoid alkaloid isolated from Buchenavia capitata, and has been shown to exhibit anti-HIV activity.

   

Isoochotensine

Isoochotensine

C21H21NO4 (351.1471)


   
   

1-epi-australine-2-O-beta-D-glucopyranoside

1-epi-australine-2-O-beta-D-glucopyranoside

C14H25NO9 (351.1529)


   
   
   
   
   

RCS-4 N-(5-carboxypentyl) metabolite

RCS-4 N-(5-carboxypentyl) metabolite

C21H21NO4 (351.1471)


   
   
   
   
   
   
   
   

13-Methylcolumbamine

13-Methylcolumbamine

C21H21NO4 (351.1471)


   

9-Ribosyl-trans-zeatin

9-Ribosyl-trans-zeatin

C15H21N5O5 (351.1543)


CONFIDENCE standard compound; ML_ID 23

   

Cis-Zeatin-riboside-[d5]

Cis-Zeatin-riboside-[d5]

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Cis-Zeatin-riboside

Cis-Zeatin-riboside

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

trans-Zeatin-riboside

trans-Zeatin-riboside

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-Zeatin-riboside-[d5]

Trans-Zeatin-riboside-[d5]

C15H21N5O5 (351.1543)


Acquisition and generation of the data is financially supported by the Max-Planck-Society

   

Trans-zeatin riboside

N-(4-hydroxy-3-methyl-2-butenyl)adenosine

C15H21N5O5 (351.1543)


trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

9-ribosylzeatin

trans-Zeatin-riboside

C15H21N5O5 (351.1543)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.545 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.538 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.540

   

N-2-Hydroxycyclopentyladenosine

N-2-Hydroxycyclopentyladenosine

C15H21N5O5 (351.1543)


   
   
   
   
   
   
   
   
   

ribosylzeatin

2-(6-{[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]amino}-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits. trans-Zeatinriboside is a type of cytokinin precursor, acts as a major long-distance signalling form in xylem vessels, regulates leaf size and meristem activity-related traits.

   

alizapride hydrochloride

alizapride hydrochloride

C16H22ClN5O2 (351.1462)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Alizapride is a potent antiemetic, acting as a dopamine receptor antagonist. Alizapride also used in human digestive disorders[1][3].

   

Fmoc-D-Pipecolic Acid

Fmoc-D-Pipecolic Acid

C21H21NO4 (351.1471)


   

(Rac)-Rotigotine hydrochloride

(Rac)-Rotigotine hydrochloride

C19H26ClNOS (351.1424)


(Rac)-Rotigotine hydrochloride is a racemate of Rotigotine. Rotigotine is a full agonist of?dopamine receptor, a partial agonist of the?5-HT1A receptor, and an antagonist of the?α2B-adrenergic receptor, with?Kis of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

   

(R)-N-Fmoc-2-(3-butenyl)glycine

(R)-N-Fmoc-2-(3-butenyl)glycine

C21H21NO4 (351.1471)


   

N-Fmoc-L-pipecolic acid

N-Fmoc-L-pipecolic acid

C21H21NO4 (351.1471)


   

5,6,7,8-Tetrahydro-6-[propyl[2-(3-thienyl)ethyl]amino]-1-naphthalenol hydrochloride

5,6,7,8-Tetrahydro-6-[propyl[2-(3-thienyl)ethyl]amino]-1-naphthalenol hydrochloride

C19H26ClNOS (351.1424)


   
   

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(-)-(1R,3S)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

(R)-N-Fmoc-2-(2-propylenyl)alanine

(R)-N-Fmoc-2-(2-propylenyl)alanine

C21H21NO4 (351.1471)


   

4-(2-carboxy-6-nitro-phenyl)-piperazine-1-carboxylic acid tertier-butyl ester

4-(2-carboxy-6-nitro-phenyl)-piperazine-1-carboxylic acid tertier-butyl ester

C16H21N3O6 (351.143)


   

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

3-(4-METHOXYPHENYL)-5-ISOXAZOLYL]METHANAMINE

C21H21NO4 (351.1471)


   

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

2-CHLORO-5-METHYL-1,4-BENZOQUINONE

C21H21NO4 (351.1471)


   

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

(+)-(1S,3R)-N-Fmoc-3-Aminocyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

Fmoc-(S)-3-Amino-5-hexenoic acid

Fmoc-(S)-3-Amino-5-hexenoic acid

C21H21NO4 (351.1471)


   

fmoc-l-cyclopropylalanine

fmoc-l-cyclopropylalanine

C21H21NO4 (351.1471)


   

4-(BOC-PIPERAZIN-1-YL)-3-NITROBENZOIC A&

4-(BOC-PIPERAZIN-1-YL)-3-NITROBENZOIC A&

C16H21N3O6 (351.143)


   

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

2-[[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]METHYL]PHTHALIMIDE

C21H21NO4 (351.1471)


   
   

Fmoc- DL -Nip-OH

Fmoc- DL -Nip-OH

C21H21NO4 (351.1471)


   

1-Boc-4-Benzyloxy-3-formylindole

1-Boc-4-Benzyloxy-3-formylindole

C21H21NO4 (351.1471)


   

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

tert-Butyl 6-(benzyloxy)-3-formyl-1H-indole-1-carboxylate

C21H21NO4 (351.1471)


   

rotigotine hydrochloride

rotigotine hydrochloride

C19H26ClNOS (351.1424)


Rotigotine Hydrochloride (N-0923 Hydrochloride) is a full agonist of dopamine receptor, a partial agonist of the 5-HT1A receptor, and an antagonist of the α2B-adrenergic receptor, with Ki of 0.71?nM, 4-15?nM, and 83?nM for the dopamine D3 receptor and D2, D5, D4 receptors, and dopamine D1 receptor.

   

Solvent Orange 14

Solvent Orange 14

C22H17N5 (351.1484)


   

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

(1R,2R)-2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)CYCLOPENTANECARBOXYLIC ACID

C21H21NO4 (351.1471)


   

Fmoc-(R)-3-Amino-5-hexenoic acid

Fmoc-(R)-3-Amino-5-hexenoic acid

C21H21NO4 (351.1471)


   

1-N-BOC-4-(3-CARBOXY-4-NITROPHENYL)PIPERAZINE

1-N-BOC-4-(3-CARBOXY-4-NITROPHENYL)PIPERAZINE

C16H21N3O6 (351.143)


   

H-Glu-Gly-Phe-OH

H-Glu-Gly-Phe-OH

C16H21N3O6 (351.143)


   

Fmoc-D-Nip-OH

Fmoc-D-Nip-OH

C21H21NO4 (351.1471)


   

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

4-(5-(4-(Pentyloxy)phenyl)isoxazol-3-yl)benzoic acid

C21H21NO4 (351.1471)


   

FMOC-D-CYCLOPROPYLALANINE

FMOC-D-CYCLOPROPYLALANINE

C21H21NO4 (351.1471)


   

Fmoc-L-beta-Homoproline

Fmoc-L-beta-Homoproline

C21H21NO4 (351.1471)


   

Fmoc-4,5-Dehydro-L-Leucine

Fmoc-4,5-Dehydro-L-Leucine

C21H21NO4 (351.1471)


   

1-(3-AZIDO-2,3-DIDEOXY-5-O-PIVALOYL-BETA-D-ERYTHRO-PENTOFURANOSYL)-THYMINE

1-(3-AZIDO-2,3-DIDEOXY-5-O-PIVALOYL-BETA-D-ERYTHRO-PENTOFURANOSYL)-THYMINE

C15H21N5O5 (351.1543)


   

N-octyl-3-metylpyridinium hexafluorophosphate

N-octyl-3-metylpyridinium hexafluorophosphate

C14H24F6NP (351.155)


   

1-BOC-5-BENZYLOXY-3-FORMYLINDOLE

1-BOC-5-BENZYLOXY-3-FORMYLINDOLE

C21H21NO4 (351.1471)


   

1-BOC-7-BENZYLOXY-3-FORMYLINDOLE

1-BOC-7-BENZYLOXY-3-FORMYLINDOLE

C21H21NO4 (351.1471)


   

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

N-Fmoc-1-amino-1-cyclopentanecarboxylic acid

C21H21NO4 (351.1471)


   

Fmoc-D-beta-homoproline

Fmoc-D-beta-homoproline

C21H21NO4 (351.1471)


   

Fmoc-(S)-2-(2-propenyl)Ala-OH

Fmoc-(S)-2-(2-propenyl)Ala-OH

C21H21NO4 (351.1471)


   

Estradiol 3-sulfamate

Estradiol 3-sulfamate

C18H25NO4S (351.1504)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-((1S,trans)-2-Hydroxycyclopentyl)adenosine

N-((1S,trans)-2-Hydroxycyclopentyl)adenosine

C15H21N5O5 (351.1543)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites GR79236 is a highly potent, selective and orally active adenosine A1 receptor agonist with a Kis of 3.1 nM and 1300 nM for A1 and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions[1][2]. GR79236 is a highly potent, selective and orally active adenosine A1 receptor agonist with a Kis of 3.1 nM and 1300 nM for A1 and A2 receptors, respectively. GR79236 has anti-nociceptive and anti-inflammatory actions[1][2].

   

3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide

3-(difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide

C18H20F3N3O (351.1558)


   

Carbol-Fuchsin

Carbol-Fuchsin

C21H22ClN3 (351.1502)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes

   

8-(Mesitylthio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine

8-(Mesitylthio)-9-(pent-4-yn-1-yl)-9H-purin-6-amine

C19H21N5S (351.1518)


   

(1S,2S,3R,4S,5R,6S)-4-(hydroxymethyl)-6-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,5-tetrol

(1S,2S,3R,4S,5R,6S)-4-(hydroxymethyl)-6-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,5-tetrol

C14H25NO9 (351.1529)


   
   
   

L-Alanyl-L-phenylalanyl-L-aspartic acid

L-Alanyl-L-phenylalanyl-L-aspartic acid

C16H21N3O6 (351.143)


   

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

(2R,3S,5R)-2-[6-[[(1S,2S)-2-Hydroxycyclopentyl]amino]-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites

   
   

N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide

N-(3,4-dimethylphenyl)-2-[[1-(phenylmethyl)-2-imidazolyl]thio]acetamide

C20H21N3OS (351.1405)


   

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide

N-[5-(4-tert-butylphenyl)-1,3,4-thiadiazol-2-yl]-4-methylbenzamide

C20H21N3OS (351.1405)


   

O-beta-D-Xylosylzeatin

O-beta-D-Xylosylzeatin

C15H21N5O5 (351.1543)


   

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

[(3Z)-2-oxo-3-(1,3,3-trimethylindol-2-ylidene)propyl] 4-hydroxybenzoate

C21H21NO4 (351.1471)


   

Phe-Ala-Asp

Phe-Ala-Asp

C16H21N3O6 (351.143)


A tripeptide composed of L-phenylalanine, L-alanine, and L-aspartic acid joined by peptide linkages.

   
   
   
   
   

beta-D-tyvelosyl-(1->3)-N-acetyl-beta-D-galactosamine

beta-D-tyvelosyl-(1->3)-N-acetyl-beta-D-galactosamine

C14H25NO9 (351.1529)


   

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

Methyl 4-(5-{[(2-hydroxy-2-phenylethyl)amino]methyl}furan-2-yl)benzoate

C21H21NO4 (351.1471)


   
   
   
   
   
   
   
   

4,6-diphenyl-N-[(E)-pyridin-3-ylmethylideneamino]pyrimidin-2-amine

4,6-diphenyl-N-[(E)-pyridin-3-ylmethylideneamino]pyrimidin-2-amine

C22H17N5 (351.1484)


   

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

Methyl 2,2-dimethyl-5-(naphthalen-1-yliminomethyl)-4,6-dioxocyclohexane-1-carboxylate

C21H21NO4 (351.1471)


   

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

1-Benzyl-3,4-bis(methoxycarbonyl)-2-phenyl-3-pyrroline

C21H21NO4 (351.1471)


   

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

1-Methyl-2,5-diphenyl-2,5-dihydro-1H-pyrrole-3,4-dicarboxylic acid dimethyl ester

C21H21NO4 (351.1471)


   

lomefloxacin

lomefloxacin

C17H19F2N3O3 (351.1394)


A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AE - Fluoroquinolones D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors

   

beta-D-Tyvp-(1->3)-beta-D-GalpNAc

beta-D-Tyvp-(1->3)-beta-D-GalpNAc

C14H25NO9 (351.1529)


An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a beta-D-tyvelosyl residue attached at the 3-position.

   
   
   
   

IMT1

IMT1

C21H21NO4 (351.1471)


IMT1 is a first-in-class specific and noncompetitive human mitochondrial RNA polymerase (POLRMT) inhibitor. IMT1 causes a conformational change of POLRMT, which blocks substrate binding and transcription in a dose-dependent way in vitro. IMT1 reduces deoxynucleoside triphosphate levels and citric acid cycle intermediates, resulting in a marked depletion of cellular amino acid levels. IMT1 has the potential for mitochondrial transcription disorders related diseases[1].

   

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

(2-{14-methoxy-3,5,16-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-1,6,8(18),9,11(19),12,14-heptaen-12-yl}ethyl)dimethylamine

C21H21NO4 (351.1471)


   

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

14,15,16-trimethoxy-8,8-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,9(17),10,12,14-octaen-5-ol

C21H21NO4 (351.1471)


   

(2r,3r,4s,5s)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2r,3r,4s,5s)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

C18H25NO4S (351.1504)


   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]butan-1-one

C21H21NO4 (351.1471)


   

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

2-{6-[(4-hydroxy-3-methylbut-2-en-1-yl)amino]purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

3,4,11-trimethoxy-13-methyl-7,8-dihydro-6-azatetraphen-10-one

C21H21NO4 (351.1471)


   

7'-methoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6'-ol

7'-methoxy-2'-methyl-6-methylidene-2,3',4',8-tetrahydrospiro[indeno[4,5-d][1,3]dioxole-7,1'-isoquinolin]-6'-ol

C21H21NO4 (351.1471)


   

5,7-dihydroxy-6-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

5,7-dihydroxy-6-(1-methylpiperidin-2-yl)-2-phenylchromen-4-one

C21H21NO4 (351.1471)


   

7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

C21H21NO4 (351.1471)


   

7-hydroxy-5-methoxy-2-phenyl-8-(piperidin-2-yl)chromen-4-one

7-hydroxy-5-methoxy-2-phenyl-8-(piperidin-2-yl)chromen-4-one

C21H21NO4 (351.1471)


   

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaene

4,5,15,16-tetramethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,11,13,15-octaene

C21H21NO4 (351.1471)


   

15,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-1(12),2(10),3(7),8,13(18),14,16-heptaene

15,16-dimethoxy-21-methyl-4,6-dioxa-21-azapentacyclo[10.9.0.0²,¹⁰.0³,⁷.0¹³,¹⁸]henicosa-1(12),2(10),3(7),8,13(18),14,16-heptaene

C21H21NO4 (351.1471)


   

(8r,8as)-7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

(8r,8as)-7-(2h-1,3-benzodioxol-5-yl)-6-(4-hydroxyphenyl)-1,2,3,5,8,8a-hexahydroindolizin-8-ol

C21H21NO4 (351.1471)


   

(2s,3r,4s,5r)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

(2s,3r,4s,5r)-2-(6-{[(2z)-4-hydroxy-3-methylbut-2-en-1-yl]amino}purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

C15H21N5O5 (351.1543)


   

(2e)-3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

(2e)-3-methanesulfonyl-n-methyl-n-(2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}ethyl)prop-2-enamide

C18H25NO4S (351.1504)


   

3,4,10,11-tetramethoxy-5h-6-azatetraphene

3,4,10,11-tetramethoxy-5h-6-azatetraphene

C21H21NO4 (351.1471)


   

1-(hydroxymethyl)-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,4-tetrol

1-(hydroxymethyl)-5-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexane-1,2,3,4-tetrol

C14H25NO9 (351.1529)